Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report 英文论文文献.docVIP

下载本文档

4
0
约1.71万字
约 5页
2017-05-08 发布于上海
举报

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report 英文论文文献.doc

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report 英文论文文献

Hsiehetal.BMCCancer2010,10:696 /1471-2407/10/696 CASE REPORT OpenAccess Toxicriskofstereotacticbodyradiotherapyand concurrenthelicaltomotherapyfollowedby erlotinibfornon-small-celllungcancertreatment- casereport Chen-HsiHsieh1,5*,Hou-TaiChang2,Shih-ChiangLin3,Yu-JenChen5,6,Li-YingWang7,Yen-PingHsieh8, Chien-AnChen1,Ngot-SwanChong1,ShoeiLongLin9,Chun-YiChen10,Pei-WeiShueng1,4* Abstract Background:Stereotacticbodyradiationtherapy(SBRT)appliedbyhelicaltomotherapy(HT)isfeasibleforlung cancerinclinical.UsingSBRTconcurrentlywitherlotinibfornon-smallcelllungcancer(NSCLC)isnotreported previously. Ca

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report 英文论文文献.docVIP